Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali.

The worldwide dissemination of extended-spectrum beta-lactamase producing Enterobacteriaceae, (ESBL-E) and their subset producing carbapenemases (CPE), is alarming. Limited data on the prevalence of such strains in infections from patients from Sub-Saharan Africa are currently available. We determined, here, the prevalence of ESBL-E/CPE in bacteriemic patients in two teaching hospitals from Bamako (Mali), which are at the top of the health care pyramid in the country. During one year, all Enterobacteriaceae isolated from bloodstream infections (E-BSI), were collected from patients hospitalized at the Point G University Teaching Hospital and the pediatric units of Gabriel Touré University Teaching Hospital. Antibiotic susceptibility testing, enzyme characterization and strain relatedness were determined. A total of 77 patients had an E-BSI and as many as 48 (62.3%) were infected with an ESBL-E. ESBL-E BSI were associated with a previous hospitalization (OR 3.97 95% IC [1.32; 13.21]) and were more frequent in hospital-acquired episodes (OR 3.66 95% IC [1.07; 13.38]). Among the 82 isolated Enterobacteriaceae, 58.5% were ESBL-E (20/31 Escherichia coli, 20/26 Klebsiella pneumoniae and 8/15 Enterobacter cloacae). The remaining (5 Salmonella Enteritidis, 3 Morganella morganii 1 Proteus mirabilis and 1 Leclercia adecarboxylata) were ESBL negative. CTX-M-1 group enzymes were highly prevalent (89.6%) among ESBLs; the remaining ones being SHV. One E. coli produced an OXA-181 carbapenemase, which is the first CPE described in Mali. The analysis of ESBL-E relatedness suggested a high rate of cross transmission between patients. In conclusion, even if CPE are still rare for the moment, the high rate of ESBL-BSI and frequent cross transmission probably impose a high medical and economic burden to Malian hospitals

Risks factor for ESBL producing <i>Enterobacteriaceae</i> bloodstream infections.

<p>Risks factor for ESBL producing <i>Enterobacteriaceae</i> bloodstream infections.</p

Antibiotic resistance rate of <i>Enterobacteriaceae</i> isolated from bloodstream infections.

<p>Antibiotic resistance rate of <i>Enterobacteriaceae</i> isolated from bloodstream infections.</p

Genetic relatedness (Rep-PCR) between ESBL producing <i>Enterobacteriaceae</i> isolated from bacteriemic patients hospitalized in referral centers in Bamako (Mali).

<p>(a) ESBL-producing <i>E</i>. <i>coli</i>, n = 20. (<b>b</b>) ESBL-producing <i>K</i>. <i>pneumonia</i>, n = 20 and (<b>c</b>) ESBL-producing <i>E</i>. <i>cloacae</i>, <i>n = 8</i>. PG = Point G University teaching hospital (adults), GT = Gabriel Touré University teaching hospital (pediatric).</p

Antibiotic resistance rate according to the ESBL phenotype.

<p>Antibiotic resistance rate according to the ESBL phenotype.</p

Prevalence and characterization of ESBL and carbapenemase.

<p>Prevalence and characterization of ESBL and carbapenemase.</p